Mirror Therapy Device for Stroke
Trial Summary
What is the purpose of this trial?
This study is a randomized and open comparative study that uses two parallel groups: a control group training with conventional therapy and another group that trains with the device "Miraπ". The participants are patients with stroke with motor weakness in one hand. Two measurement visits are required. During those visits, different hand function assessments will be carried out to analyze the motor function of the subjects hand. The measurements will be done during their inpatient rehabilitation stay, one at time of admission and the second at discharge, each taking 20 minutes. In the time between the measurement visits, the hand therapy takes place fivemtimes a week.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the Mirror Therapy Device for stroke treatment?
Is mirror therapy safe for humans?
Mirror therapy is generally considered safe for humans, as it involves using a mirror to create a visual illusion that can help with rehabilitation, particularly in stroke patients. There are no reports of harmful effects, but some studies suggest it may cause a shift in weight and leaning towards the unaffected side during therapy.23467
How is the Mirror Therapy treatment for stroke different from other treatments?
Mirror Therapy is unique because it uses a mirror to create the illusion that the affected limb is moving, which helps the brain rewire itself to improve movement in the affected limb. This approach is different from other treatments as it focuses on visual feedback and mental imagery to enhance motor recovery.34689
Research Team
Rummana Aslam, MD
Principal Investigator
Yale University
Eligibility Criteria
This trial is for stroke patients with motor weakness in one hand. They must be able to participate in therapy five times a week during their inpatient rehabilitation stay and attend two measurement visits.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive hand therapy five times a week using either conventional Mirror Therapy or the Miraπ device
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Miraπ
- Mirror Therapy
Mirror Therapy is already approved in European Union, United States for the following indications:
- Stroke rehabilitation
- Motor weakness in one hand
- Stroke rehabilitation
- Motor weakness in one hand
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor
Management Center Innsbruck (MCI), Austria
Collaborator
Yale School of Engineering Center for Engineering 26 Innovation and Design
Collaborator
Yale School of Engineering Center for Engineering Innovation and Design
Collaborator